Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency’s review of Anaphylm NDA ...
The support measures include incentives on loans, taxes and customs duties, as well as a system of grants, internships and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback